A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

被引:26
|
作者
Sime, Fekade B. [1 ,2 ]
Lassig-Smith, Melissa [3 ]
Starr, Therese [3 ]
Stuart, Janine [3 ]
Pandey, Saurabh [1 ]
Parker, Suzanne L. [1 ]
Wallis, Steven C. [1 ]
Lipman, Jeffrey [1 ,3 ,4 ]
Roberts, Jason A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Queensland, Ctr Clin Res, Fac Med, Brisbane, Qld, Australia
[2] Univ Queensland, Ctr Translat Antiinfect Pharmacodynam, Sch Pharm, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[4] Univ Montpellier, Nimes Univ Hosp, Div Anaesthesiol Crit Care Emergency & Pain Med, Nimes, France
[5] Royal Brisbane & Womens Hosp, Pharm Dept, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
ceftolozane-tazobactam; pharmacokinetics; renal replacement therapy; hemodiafiltration; CRRT; RENAL REPLACEMENT THERAPY; PSEUDOMONAS-AERUGINOSA; CLEARANCE;
D O I
10.1128/AAC.01655-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aim of this work was to describe optimized dosing regimens of ceftolozane-tazobactam for critically ill patients receiving continuous venovenous hemodiafiltration (CVVHDF). We conducted a prospective observational pharmacokinetic study in adult critically ill patients with clinical indications for ceftolozane-tazobactam and CVVHDF. Unbound drug concentrations were measured from serial prefilter blood, postfilter blood, and ultrafiltrate samples by a chromatographic assay. Population pharmacokinetic modeling and dosing simulations were performed using Pmetrics. A four-compartment pharmacokinetic model adequately described the data from six patients. The mean (+/- standard deviation [SD]) extraction ratios for ceftolozane and tazobactam were 0.76 +/- 0.08 and 0.73 +/- 0.1, respectively. The mean +/- SD sieving coefficients were 0.94 +/- 0.24 and 1.08 +/- 0.30, respectively. Model-estimated CVVHDF clearance rates were 2.7 +/- 0.8 and 3.0 +/- 0.6 liters/h, respectively. Residual non-CVVHDF clearance rates were 0.6 +/- 0.5 and 3.3 +/- 0.9 liters/h, respectively. In the initial 24 h, doses as low as 0.75 g every 8 h enabled cumulative fractional response of >= 85% for empirical coverage against Pseudomonas aeruginosa, considering a 40% fT (>MIC) (percentage of time the free drug concentration was above the MIC) target. For 100% fT (>MIC), doses of at least 1.5 g every 8 h were required. The median (interquartile range) steady-state trough ceftolozane concentrations for simulated regimens of 1.5 g and 3.0 g every 8 h were 28 (21 to 42) and 56 (42 to 84) mg/liter, respectively. The corresponding tazobactam concentrations were 6.1 (5.5 to 6.7) and 12.1 (11.0 to 13.4) mg/liter, respectively. We suggest a front-loaded regimen with a single 3.0-g loading dose followed by 0.75 g every 8 h for critically ill patients undergoing CVVHDF with study blood and dialysate flow rates.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [31] Measurement and calculation of the extracorporeal elimination of vancomycin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Muhl, E
    Bundesen, J
    Iven, H
    Bruch, HP
    JOURNAL OF INTENSIVE CARE MEDICINE, 2001, 16 (05) : 222 - 230
  • [32] Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and monte carlo simulation
    H Barrasa González
    A Martín López
    A Isla Ruiz
    A Rodríguez Gascón
    A Soraluce Olañeta
    E Asín Prieto
    A Canut Blasco
    JA Sánchez Izquierdo
    B Fernández Miret
    A Vallejo De la Cueva
    FJ Maynar Moliner
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [33] Colistin Methanesulfonate and Colistin Pharmacokinetics in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration
    Karvanen, Matti
    Plachouras, Diamantis
    Friberg, Lena E.
    Paramythiotou, Elisabeth
    Papadomichelakis, Evangelos
    Karaiskos, Ilias
    Tsangaris, Iraklis
    Armaganidis, Apostolos
    Cars, Otto
    Giamarellou, Helen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 668 - 671
  • [34] Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients
    Robatel, C
    Decosterd, LA
    Biollaz, J
    Eckert, P
    Schaller, MD
    Buclin, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (12): : 1329 - 1340
  • [35] Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
    B Meyer
    G Kornek
    M Nikfardjam
    G Delle Karth
    G Heinz
    G Locker
    W Jaeger
    F Thalhammer
    Critical Care, 8 (Suppl 1):
  • [36] Pharmacokinetics of vancomycin in critically ill patients undergoing continuous venovenous haemodialysis
    Chaijamorn, Weerachai
    Wanakamanee, Usanee
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (04) : 367 - 368
  • [37] Novel Population Pharmacokinetic Model for Linezolid in Critically Ill Patients and Evaluation of the Adequacy of the Current Dosing Recommendation
    Soraluce, Amaia
    Barrasa, Helena
    Asin-Prieto, Eduardo
    Angel Sanchez-Izquierdo, Jose
    Maynar, Javier
    Isla, Arantxazu
    Rodriguez-Gascon, Alicia
    PHARMACEUTICS, 2020, 12 (01)
  • [38] Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltration
    Wieringa, Andre
    ter Horst, Peter G. J.
    Wagenvoort, GertJan H. J.
    Koch, Birgit C. P.
    Haringman, Jasper J.
    ANTIVIRAL THERAPY, 2023, 28 (01)
  • [39] Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration
    Capellier, G
    Cornette, C
    Boillot, A
    Guinchard, C
    Jacques, T
    Blasco, G
    Barale, F
    CRITICAL CARE MEDICINE, 1998, 26 (01) : 88 - 91
  • [40] OPTIMIZE CEFEPIME DOSING IN CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Lin, Hsin
    Boidin, Clement
    Evans, Danielle
    Lopez, Natasha
    Healy, Daniel
    Serpico, Elena
    Goutelle, Sylvain
    Roberts, Jason
    CRITICAL CARE MEDICINE, 2019, 47